
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.100 | 0.100 | 0.000 |
Shares | 99.890 | 99.960 | 0.070 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.003 | 18.647 |
Price to Book | 2.565 | 3.060 |
Price to Sales | 2.421 | 2.274 |
Price to Cash Flow | 14.499 | 12.145 |
Dividend Yield | 1.646 | 2.050 |
5 Years Earnings Growth | 12.897 | 9.680 |
Name | Net % | Category Average |
---|---|---|
Technology | 22.260 | 24.378 |
Financial Services | 19.790 | 16.889 |
Industrials | 11.150 | 12.126 |
Consumer Cyclical | 10.640 | 10.393 |
Communication Services | 9.210 | 8.170 |
Healthcare | 9.200 | 12.122 |
Consumer Defensive | 4.970 | 7.317 |
Basic Materials | 4.180 | 3.940 |
Energy | 4.130 | 3.338 |
Utilities | 2.810 | 2.539 |
Real Estate | 1.660 | 2.760 |
Number of long holdings: 331
Number of short holdings: 12
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Apple Inc | - | 4.09 | - | - | |
Microsoft Corp | - | 3.30 | - | - | |
Amazon.com Inc | - | 2.38 | - | - | |
Alphabet Inc A | - | 1.36 | - | - | |
Facebook Inc A | - | 1.32 | - | - | |
Alphabet Inc Class C | - | 1.29 | - | - | |
JPMorgan Chase & Co | - | 1.17 | - | - | |
UnitedHealth Group Inc | - | 0.97 | - | - | |
Johnson & Johnson | - | 0.93 | - | - | |
Tesla Inc | - | 0.90 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Deka GlobalChampions CF | 9.98B | 0.44 | 13.45 | 10.74 | ||
DekaFonds CF | 6.06B | 17.51 | 17.35 | 5.46 | ||
AriDeka CF | 2.93B | 7.15 | 11.03 | 4.80 | ||
ZukunftsPlan I | 2.93B | 1.87 | 9.70 | 6.61 | ||
Deka-MegaTrends CF | 3.02B | -3.72 | 11.02 | 9.55 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review